期刊文献+

核医学显像与胰腺内分泌肿瘤的诊断和治疗

Nuclear medical imaging in the diagnosis and treatment of endocrine pancreatic tumors
原文传递
导出
摘要 胰腺内分泌肿瘤(EPTs)是一组具有不同临床表现、生物学行为以及预后的肿瘤的总称;其显著特征为大部分肿瘤细胞存在神经胺摄取机制和(或)细胞表面表达特殊受体,这些都为核医学显像在诊疗EPTs方面提供了依据。随着核医学技术的发展,尤其是PET与CT实现了解剖与功能的完美结合,核医学显像在探查EPTs微小病灶、早期发现转移灶以及治疗方面具有独到的优势。 Endocrine pancreatic tumors (EPTs) are a heterogeneous group of neoplasms with variable manifestations, biological features and prognosis, which are characterized by the presence of neuroamine uptake mechanisms and (or) peptide receptors on the cell membrane. All these features constitute the basis for the clinical use of nuclear medicine examination methods, both for imaging diagnosis and therapy. With the development of nuclear medicine technologies, especially the exquisite hybrid positron emission tomography/ computed tomography (PET/CT), bringing about perfect combination with anatomic location and functional metabolism ,they have specific advantages for small lesion probe, early metastasis detection and therapy.
出处 《国际内分泌代谢杂志》 北大核心 2013年第2期99-103,共5页 International Journal of Endocrinology and Metabolism
关键词 胰腺内分泌肿瘤 核医学显像 PET CT 肽标记配体 Endocrine pancreatic tumors Nuclear medicine imaging PET/CT Peptide-labeled ligand
  • 相关文献

参考文献35

  • 1Alexakis N, Neoptolemos JP. Pancreatic neuroendocrine tumours. Best Pract Res Clin Gastroenterol,2008 ,22 :183-205.
  • 2Rufini V, Baum RP, Castaldi P, et al. Role of PET/CT in the functional imaging of endocrine pancreatic tumors. Abdom Imaging,2012,37 : 1004-1020.
  • 3O'Grady HL, Conlon KC. Pancreatic neuroendocrine tumours. Eur J Surg Onco1,2008 ,34 :324-332.
  • 4Jager PL, Chirakal R, Marriott C J, et al. 6-L-is F-fluorodihydroxy- phenylalanine PET in neuroendocrine tumors: basic aspects and emerging clinical applications. J Nucl Med ,2008,49:573-586.
  • 5Ismail D, Hussain K. Role of is F-DOPA PET/CT imaging in congenital hyperinsulinism. Rev Endocr Metab Disord,2010,11:165- 169.
  • 6Kauhanen S, Seppanen M, Minn H, et al. Fluorine-18-L-dihydroxy- phenylalanine (lSF-DOPA) positron emission tomography as a tool to localize an insulinoma or beta-cell hyperplasia in adult patients. J Clin Endocrinol Metab ,2007,92 : 1237-1244.
  • 7Tessonnier L, Sebag F, Ghander C, et al. Limited value of ^18F-F- DOPA PET to localize pancreatic insulin-secreting tumors in adults with hyperinsulinemic hypoglycemia. J Clin Endocrinol Metab ,2010,95:303-307.
  • 8Orlefors H, Sundin A, Garske U, et al. Whole-body ( 11 ) C-5- hydroxytryptophan positron emission tomography as a universal imaging technique for neuroendocrine tumors: comparison with so- matostatin receptor seintigraphy and computed tomography. J Clin Endocrinol Metab ,2005,90:3392-3400.
  • 9Sundin A, Erlksson B, Bergstrom M, et al. PET in the diagnosis of neuroendocrine tumors. Ann N Y Acad Sci,2004,1014:246-257.
  • 10Kramer SD,Mu L,MUller A,et al. 5-(2-18F-fluoroethoxy)-Ltryptophan as a substrate of system L transport for tumor imaging by PET. J Nucl Med ,2012 ,53 :434442.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部